Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Egle Therapeutics S.A.S.
BioCentury | Jan 15, 2025
Management Tracks
Auspitz becomes managing partner at Curie.bio
Plus: Amphista names Paul Medeiro CBO, and updates from Apellis, Forbion, Eqt, Egle, Spero, Molecular Templates and more
BioCentury | Sep 14, 2024
Management Tracks
Egle names Detheux chairman
Plus: BeiGene adds to commercial leadership, hiring Pfizer veteran Matt Shaulis, and updates from Wells Fargo, Flagship, Alume, Cytek, Aetion and 180 Life Sciences
BioCentury | Jul 3, 2024
Management Tracks
CSO Kilty replaces Weir as Sitryx CEO
Plus: Y-mAbs hires Peter Pfreundschuh as CFO, and updates from LIfT,
BioCentury | May 22, 2024
Discovery & Translation
Science Spotlight: GLP1-NMDA for obesity, anti-ceramide for diabetic retinopathy, and more
BioCentury’s roundup of translational innovations
BioCentury | May 14, 2024
Management Tracks
John Milad named CEO of CRISPR play ERS Genomics
Plus: Senhwa hires Jason Huang as CMO, and updates from Egle and The Jackson Laboratory
BioCentury | Mar 27, 2024
Management Tracks
Furuta to become CFO at Takeda
Plus: IDRx names Kerstein CMO and updates from Transgene, Noetik, Egle and MannKind
BioCentury | Sep 7, 2022
Management Tracks
Harpoon’s McMahon becomes CEO at Storm
Plus new CFO, CSO at Voyager and updates from Sonoma, Garuda, Alloy, Homology and more
BioCentury | May 5, 2022
Management Tracks
Legault named Egle chairman
Plus Tom Hughes becomes chairman of Totus, and updates from Immunicum, Kbio and more
BioCentury | Nov 10, 2021
Finance
PE takeout frees up LSP’s team, promises bigger funds
Deal comes on back of raising Europe’s largest life sciences fund LSP 7 with first close at near $1 billion
BioCentury | Oct 23, 2021
Product Development
Oct. 22 Quick Takes: FDA approves Genentech’s ocular implant for wet AMD
$118M IPO values Xilio at $427M, plus Genentech, Merck, Sanofi and more
Items per page:
1 - 10 of 10